CSIMarket
 


Waters Corp  (WAT)
Other Ticker:  
 

Cumulative Waters's Long Term Debt to Equity for Trailing Twelve Months Period

WAT's Long Term Debt to Equity for Trailing Twelve Months Period and Long Term Debt, Equity growth


Select the Comparisons : Select the Ratio:

WAT Long Term Debt to Equity for Trailing Twelve Months Period

(Dec 31 2018)
IV. Quarter
(Sep 29 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Equity Growth -29.84 % -28.63 % -21.58 % -11.69 % -2.96 %
Y / Y Long Term Debt Growth -39.49 % -33.73 % -31.96 % -24.02 % 11.49 %
Long Term Debt to Equity for Trailing Twelve Months Period 0.62 0.66 0.67 0.69 0.71
Total Ranking # 1894 # 1852 # 1875 # 1991 # 1832
Seq. Equity Growth -16.48 % -5 % -6.61 % -5.32 % -15.04 %
Seq. Long Term Debt Growth 0.01 % 0.01 % -7.99 % -34.25 % 9.53 %


Long Term Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2018
On the trailing twelve months basis Despite net new long-term borrowings of 0.01% Waters managed to decrease Long Term Debt to Equity for Trailing Twelve Months Period in IV. Quarter to 0.62, below Waters's average Long Term Debt to Equity for Trailing Twelve Months Period.
Long Term Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Laboratory Analytical Instruments industry 13 other companies have achieved lower Long Term Debt to Equity for Trailing Twelve Months Period than Waters. While total ranking remained unchanged compare to previous quarter at no. .

What is Long Term Debt to Equity Ratio?
What is WAT selling?
Long Term Debt to Equity WAT in the most recent quarter
Long Term Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 14
Sector # 305
S&P 500 # 2045


Long Term Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
1.9 0.82 0.47
(Sep. 30, 2006)   (Sep. 30, 2005)




Companies with similar average Long Term Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2018, within Laboratory Analytical Instruments Industry Long Term Debt to Equity for Trailing Twelve Months Period
Accelerate Diagnostics Inc   0.94 
Perkinelmer Inc  0.75 
Bionano Genomics Inc   0.71 
Waters Corp  0.70 
Harvard Bioscience Inc  0.58 
Cue Health Inc   0.54 
Eyepoint Pharmaceuticals Inc   0.46 
Htg Molecular Diagnostics Inc  0.44 
Agilent Technologies inc   0.38 
Bruker Corporation  0.36 
Illumina Inc   0.27 
Lifeloc Technologies Inc   0.23 
Precipio inc   0.19 
Pacific Biosciences Of California Inc   0.13 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com